Advisory Alpha, LLC Novavax Inc Transaction History

Advisory Alpha, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$78.74 - $139.5 $1,181 - $2,092	-15 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$79.44 - $178.51 $1,191 - $2,677	15 New	15 $220,000
Q2 2020 Aug 14, 2020	SELL	$13.86 - $83.61 $4,227 - $25,501	-305 Closed	0 $0
Q1 2020 Apr 29, 2020	BUY	$3.93 - $16.0 $1,198 - $4,880	305 New	305 $6.22 Million

291

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $704M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Advisory Alpha, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Alpha, LLC with notifications on news.